Context TherapeuticsCNTX
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 39 institutions reported holding Context Therapeutics Inc. (CNTX) in their 13F filings, down 3 from Q1 2025. 4 opened new positions and 7 sold out. The largest holders were MPM Bioimpact LLC ($9.6M), Avidity Partners Management LP ($4.9M) and Nextech Invest Ltd. ($4.9M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Context Therapeutics Inc.
- CUSIP
- 21077P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $314K |
| Exits | 7 | $1.5M |
All 13F filers, Q1 2025 → Q2 2025: 663,482 shares bought and 3,449,870 shares sold, net −2,786,388 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| MPM Bioimpact LLC | 1.67% | No change | 14,705,882 | $9.6M |
| Avidity Partners Management LP | 0.98% | Add +0.0% | 7,477,255 | $4.9M |
| Nextech Invest Ltd. | 0.92% | No change | 7,419,355 | $4.9M |
| Deep Track Capital, LP | 0.16% | No change | 7,419,355 | $4.9M |
| Blue Owl Capital Holdings LP | 1.57% | Add +0.5% | 7,407,906 | $4.9M |
| Great Point Partners LLC | 2.00% | No change | 4,683,711 | $3.1M |
| Franklin Resources Inc. | 0.00% | No change | 4,003,380 | $2.6M |
| Vanguard Group Inc. | 0.00% | Add +3.3% | 3,360,582 | $2.2M |
| Blackstone Inc. | 0.01% | No change | 2,440,330 | $1.6M |
| Nantahala Capital Management, LLC | 0.09% | No change | 1,935,484 | $1.3M |
| Alyeska Investment Group, L.P. | 0.00% | No change | 1,663,355 | $1.1M |
| Sio Capital Management, LLC | 0.35% | Add +1.0% | 1,341,636 | $879K |
| BlackRock, Inc. | 0.00% | No change | 848,970 | $556K |
| Woodline Partners LP | 0.00% | Reduce -50.0% | 680,188 | $446K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.2% | 637,810 | $418K |
| Affinity Asset Advisors, LLC | 0.05% | Reduce -21.6% | 518,025 | $339K |
| Renaissance Technologies | 0.00% | Reduce -14.5% | 363,930 | $238K |
| ADAR1 Capital Management, LLC | 0.04% | No change | 351,094 | $230K |
| Luminus Management LLC | 0.06% | New | 328,222 | $215K |
| State Street Corp. | 0.00% | No change | 152,607 | $100K |
| Walleye Capital LLC | 0.00% | Reduce -21.4% | 132,786 | $87K |
| HighTower Advisors, LLC | 0.00% | No change | 125,852 | $82K |
| Northern Trust Corp. | 0.00% | No change | 113,565 | $74K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -38.7% | 106,779 | $70K |
| Mill Creek Capital Advisors, LLC | 0.00% | New | 104,631 | $69K |
| Velan Capital Investment Management LP | 0.07% | Add +11.1% | 100,000 | $66K |
| Clear Harbor Asset Management, LLC | 0.00% | No change | 57,804 | $38K |
| GTS Securities LLC | 0.00% | New | 44,176 | $29K |
| Cerity Partners LLC | 0.00% | Add +100.0% | 20,000 | $13K |
| Caxton Corp. | 0.12% | No change | 18,403 | $12K |
| Millennium Management | 0.00% | Reduce -64.9% | 17,067 | $11K |
| CW Advisors, LLC | 0.00% | No change | 15,000 | $10K |
| Osaic Holdings, Inc. | 0.00% | Add +5.0% | 10,500 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -44.3% | 7,414 | $5K |
| Morgan Stanley | 0.00% | Add +3400.0% | 3,500 | $2K |
| NFSG Corp | 0.00% | New | 2,000 | $1K |
| Bank of America Corp. | 0.00% | Add +22.3% | 543 | $356 |
| UBS Group AG | 0.00% | Reduce -14.3% | 370 | $242 |
| SBI Securities Co., Ltd. | 0.00% | No change | 113 | $74 |
"% of holder's portfolio" is CNTX's weight in each manager's 13F, not the share of Context Therapeutics Inc. the manager owns.